论文信息 - A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia - 字舞流文

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

P. Rousselot | M. Delord | S. Rigaudeau | H. Farhat | M. Spentchian | C. Besson | S. Marque-Juillet | A. Cabannes-Hamy | A. Roupie | N. Lombion | F. Merabet | Victoria Raggueneau | A. Guemriche | Jennifer Osman | M. Kohn | Maureen Chbat | Thomas Longval | J. Lambert